Tumor targeted mesoporous silica nanoparticles functionalized with programmed death receptor ligand-1 antibody (anti-PD-L1) for combined chemo- and immunotherapy

Saved in:
Bibliographic Details
Published inBiophysical journal Vol. 121; no. 3; p. 421a
Main Authors Loganathan, Palanikumar, Magzoub, Mazin
Format Journal Article
LanguageEnglish
Published Elsevier Inc 11.02.2022
Online AccessGet full text

Cover

More Information
ISSN:0006-3495
1542-0086
DOI:10.1016/j.bpj.2021.11.660